Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valnoctamide as a Valproate Substitute in Bipolar Disorder
NCT00140179Phase 3Completed
- Sponsor
- Be'er Sheva Mental Health Center
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valnoctamide in mania, schizoaffective disorder, sponsored by Be'er Sheva Mental Health Center. Started Sep 2004; status: completed.
02
Drugs
valnoctamide
03
Conditions
maniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00140179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140179.